Pulse Biosciences, Inc.

PLSE · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$118,038$44,365$61,139$28,614
Short-Term Investments$0$0$0$0
Receivables$0$0$0$61
Inventory$0$0$0$5,824
Other Curr. Assets$1,411$963$1,008$2,131
Total Curr. Assets$119,449$45,328$62,147$36,630
Property Plant & Equip (Net)$8,323$8,784$10,023$11,247
Goodwill$2,791$2,791$2,791$2,791
Intangibles$1,220$1,886$2,551$3,216
Long-Term Investments$0$1,886-$2,725-$3,255
Tax Assets$0$0$2,725$3,255
Other NC Assets$677-$1,521$365$365
Total NC Assets$13,011$13,826$15,730$17,619
Other Assets$0$0$0$0
Total Assets$132,460$59,154$77,877$54,249
Liabilities
Payables$1,673$1,836$1,573$2,904
Short-Term Debt$1,355$1,058$1,813$1,210
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$16
Other Curr. Liab.$7,027$3,814$2,595$4,389
Total Curr. Liab.$10,055$6,708$5,981$8,519
LT Debt$7,543$8,086$74,144$10,040
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$7,543$8,086$74,144$10,040
Other Liabilities$0$0$0$0
Cap. Leases$8,898$9,144$10,040$10,814
Total Liabilities$17,598$14,794$80,125$18,559
Equity
Pref Stock$0$0$0$0
Common Stock$66$55$37$29
Retained Earnings-$390,500-$336,915-$294,705-$236,200
AOCI$0$0$0$0
Other Equity$505,296$381,220$292,420$271,861
Total Equity$114,862$44,360-$2,248$35,690
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$132,460$59,154$77,877$54,249
Net Debt-$109,140-$35,221$14,818-$17,364